MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1007/s00595-026-03377-y

Медицинская библиотека · Surgery today · 2026

Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases.

Kanemitsu Kosuke, Hayashi Hiromitsu, Tagayasu Yoshiyuki, Tanizaki Takumi, Adachi Yuki, Ofuchi Takashi, Tajiri Takuya, Kitano Yuki, Okabe Hirohisa, Iwatsuki Masaaki

СтатьяПеревод пока не подготовлен

Аннотация

PURPOSES: The Kirsten rat sarcoma viral oncogene homolog (KRAS) is defined as frequently mutated oncogenes in colorectal cancer. We aimed to clarify the clinical impact of KRAS mutation status on recurrence patterns, the surgical management of recurrent lesions, and prognostic outcomes after curative hepatectomy for colorectal liver metastases (CRLM).

METHODS

The subjects of this retrospective study were 190 patients who underwent curative (macroscopic R0 resection) hepatectomy for CRLM and had wild-type (62.1%) or mutant (37.9%) KRAS status.

RESULTS

KRAS mutations were associated with significantly worse overall survival (OS) and recurrence-free survival (RFS), as well as more aggressive recurrence patterns. Multivariate analysis identified KRAS mutation as an independent predictor of poor OS and RFS, whereas CEA ≥ 5 ng/mL was independently associated with OS but not RFS. Notably, patients from the mutant KRAS and wild-type KRAS groups who underwent local therapy (as repeat resection or ablation) for local recurrence had comparable OS. Conversely, among the patients who did not receive local therapy, those from the mutant KRAS group had significantly worse OS than those from the wild-type KRAS group.

CONCLUSIONS

KRAS mutations are associated with aggressive recurrence patterns and a poor prognosis for patients with CRLM. However, survival following local therapy for recurrence appeared less pronounced regardless of KRAS status.

Для цитирования: Kanemitsu Kosuke, Hayashi Hiromitsu, Tagayasu Yoshiyuki, Tanizaki Takumi, Adachi Yuki, Ofuchi Takashi, Tajiri Takuya, Kitano Yuki, Okabe Hirohisa, Iwatsuki Masaaki. Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases.. Surgery today. 2026. DOI: 10.1007/s00595-026-03377-y.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.